A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

BACKGROUND: To better evaluate and improve the efficacy of dendritic cell (DC)-based cancer immunotherapy, we conducted a clinical study of patients with advanced colorectal cancer using carcinoembryonic antigen (CEA)-pulsed DCs mixed with tetanus toxoid and subsequent interleukin-2 treatment. The t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ko-Jiunn, Chao, Tsu-Yi, Chang, Jang-Yang, Cheng, Ann-Lii, Ch’ang, Hui-Ju, Kao, Woei-Yau, Wu, Yu-Chen, Yu, Wei-Lan, Chung, Tsai-Rong, Whang-Peng, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997699/
https://www.ncbi.nlm.nih.gov/pubmed/27558635
http://dx.doi.org/10.1186/s12929-016-0279-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997699/
https://www.ncbi.nlm.nih.gov/pubmed/27558635
http://dx.doi.org/10.1186/s12929-016-0279-7

Ejemplares similares